Having trouble viewing this email? View in your browser.
ESCMID Logo

28 November 2017
WEEKLY NEWS

Dear colleagues,

We are pleased to announce that we will be accepting applications for our new-look observership programme in December 2017. To allow more people to benefit from our popular programme in a fairer way, we will be offering funded opportunities for which young scientist members can apply twice a year, along with unfunded opportunities to allow more of you to visit your chosen ECC throughout the year. Look out for confirmed dates of the next call for applications being announced in this newsletter in the coming weeks.

Best regards, your ESCMID communications editors

 

Abstract submission for ECCMID 2018 in Madrid closes 30 November!

Be part of another record-breaking ECCMID! Share and discuss the research you are currently working on with colleagues from around the world. We expect to accept about three quarters of around 5,000 abstracts that are likely to be submitted for presentation at our congress from 21 – 24 April 2018. Abstracts may be submitted until 30 November 2017 at 23.59 CET. The abstract topics and the abstract guidelines can be found on the website. You will also find a tutorial video to guide you through the process if you have never submitted an abstract to ECCMID.

› Read more
 

CMI highlight: birth outcomes associated with Zika during pregnancy

Researchers in Brazil report the first 54 cases of pregnant women infected by Zika virus (ZIKV) and their virological and clinical outcomes, as well as the newborns’ outcomes in 2016, after the emergence of ZIKV in dengue endemic areas of São Paulo. Of 216 acute Zika-suspected pregnant women 54 had the diagnosis confirmed by RT-PCR. None of the 54 women miscarried. Among the 54 newborns, 15 exhibited adverse outcomes at birth. The highest number of ZIKV infections occurred during the second and third trimesters. No cases of microcephaly were reported, though the broad clinical spectrum of outcomes, as lenticulostriate vasculopathy, subependymal cysts, auditive and ophtalmological disorders, were identified. ZIKV RNA was detected in 18 of 51 newborns tested and in eight of 15 newborns with adverse outcomes. Although other studies have associated many newborn outcomes to ZIKV infection during pregnancy, these same adverse outcomes were rare or non-existent in this study. The clinical presentation in newborns was mild compared to other reports, suggesting that there is significant heterogeneity of congenital Zika infection, the authors conclude (open-access paper).

› Read more
 

ESGAP, ESGCIP endorse declaration on AMR threat in surgical infections

ESCMID’s study group for antimicrobial stewardship (ESGAP) and its study group for infections in critically ill patients (ESGCIP) endorsed a declaration highlighting the threat posed by antimicrobial resistance and the need for appropriate use of antibiotic agents and antifungal agents in hospitals worldwide, especially focusing on surgical infections. The declaration promoted by the Global Alliance for Infections in Surgery and the World Society of Emergency Surgery (WSES) was signed by an interdisciplinary task force of 234 experts from 83 different countries.

› Read more
 

Guideline for C. diff prevention open for public consultation

The draft version of the guideline for the prevention of Clostridium difficile infection in acute healthcare settings is open for public consultation. The guideline is a result of the concerted efforts of experts across Europe. Those of you wishing to comment on the manuscript may write to the ESCMID Publications and Medical Guidelines Manager to request the (confidential) draft of the manuscript along with the comments form for listing feedback. We are happy to receive your feedback and comments on the manuscript by 13 December 2017 EOB (CET). Please be aware that your comments and the authors’ responses to the comments will be made available online once the guideline is published.

› Read more
 

ESCMID members now receive Kucers’ The Use of Antibiotics at discount

ESCMID members who are interested to purchase the three-volume set of Kucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs (7th Edition) benefit from a 20% reduction on the regular price of GBP449. Please send an email to the ESCMID membership manager to receive the promotion code.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.